The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy

OBJECTIVE: To assess whether neuropathy with anti-myelin-associated glycoprotein (MAG) antibody may improve after treatment with ibrutinib, an oral inhibitor of Bruton tyrosine kinase, we prospectively treated with ibrutinib a cohort of 3 patients with anti-MAG neuropathy and Waldenström macroglobul...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurol Neuroimmunol Neuroinflamm
Main Authors: Castellani, Francesca, Visentin, Andrea, Campagnolo, Marta, Salvalaggio, Alessandro, Cacciavillani, Mario, Candiotto, Cinzia, Bertorelle, Roberta, Trentin, Livio, Briani, Chiara
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7176252/
https://ncbi.nlm.nih.gov/pubmed/32284437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000720
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares